Dingdang Health Technology Group

Dingdang Health Technology Group FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Dingdang Health Technology Group (9886.HK) as of Nov 2, 2026 is -249.99 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 9.68 % — a change of -2,682.07% (lower).

FCF Conversion

-249.99 %

YoY

-2,682.07%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Dingdang Health Technology Group is 2025 -249.99 % . FCF Conversion Rate (FCF/EBITDA) of Dingdang Health Technology Group was 2024 9.68 % . It decreases by -2,682.07% lower compared to the previous year.

The Dingdang Health Technology Group FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2018
3.07 CNY
Jan 1, 2019
123.35 CNY
Jan 1, 2020
23.66 CNY
Jan 1, 2021
24.46 CNY
Jan 1, 2022
11.23 CNY
Jan 1, 2023
13.34 CNY
Jan 1, 2024
9.68 CNY
Jan 1, 2025
-249.99 CNY
The Dingdang Health Technology Group FCF Conversion history
YEARFCF ConversionYoY
-249.99 %-2,682.07%
9.68 %-27.42%
13.34 %+18.78%
11.23 %-54.08%
24.46 %+3.36%
23.66 %-80.82%
123.35 %+3,921.21%
3.07 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dingdang Health Technology Group Stock analysis

What does Dingdang Health Technology Group do? Dingdang Health Technology Group Ltd. generates revenue through its Pharmaceutical and Healthcare Business segment, which offers online direct sales, business distribution, offline smart pharmacies, express delivery services, and online medical consultation. The company also earns income from the Others segment, providing marketing services, marketplace services, and other services. Its primary customers are domestic consumers and businesses within China, leveraging its domestic market focus. The firm operates two distinct business segments to serve the pharmaceutical and healthcare needs of its target market. The company's Pharmaceutical and Healthcare Business segment focuses on delivering healthcare solutions through multiple channels, including online platforms and physical smart pharmacies, while the Others segment supports these operations with complementary services like marketing and marketplace solutions. Both segments operate exclusively within the domestic market, targeting Chinese consumers and businesses seeking pharmaceutical and healthcare services. Dingdang Health Technology Group Ltd. utilizes its two business segments to maximize revenue streams from domestic healthcare service delivery. Revenue is derived from the direct sale of pharmaceutical products, distribution services, and healthcare-related online consultations, alongside marketing and marketplace services provided to other businesses. The company’s domestic market strategy ensures that all services and products are tailored to meet the needs of Chinese consumers and businesses, with no international operations. Its business model relies on the integration of online and offline services to enhance customer experience and drive sales. Dingdang Health Technology Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dingdang Health Technology Group stock

FCF Conversion Rate (FCF/EBITDA) of Dingdang Health Technology Group is -249.99 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of Dingdang Health Technology Group changed from 9.68 % to -249.99 %, representing a -2,682.07% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Dingdang Health Technology Group since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Dingdang Health Technology Group with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Dingdang Health Technology Group

All Key Metrics — Dingdang Health Technology Group